Abstract
Neurodegenerative diseases represent a growing healthcare problem, mainly related to an aging population worldwide and thus their increasing prevalence. In particular, Alzheimer’s disease (AD) and Parkinson’s disease (PD) are leading neurodegenerative diseases. To aid their diagnosis and optimize treatment, we have developed a classification algorithm for AD to manipulate magnetic resonance images (MRI) stored in a large database of patients, containing 1,200 images. The algorithm can predict whether a patient is healthy, has mild cognitive impairment, or already has AD. We then applied this classification algorithm to therapeutic outcomes in PD after treatment with deep brain stimulation (DBS), to assess which stereotactic variables were the most important to consider when performing surgery in this indication. Here, we describe the stereotactic system used for DBS procedures, and compare different planning methods with the gold standard normally used (i.e., neurophysiological coordinates recorded intraoperatively). We used information collected from database of 72 DBS electrodes implanted in PD patients, and assessed the potentially most beneficial ranges of deviation within planning and neurophysiological coordinates from the operating room, to provide neurosurgeons with additional landmarks that may help to optimize outcomes: we observed that x coordinate deviation within CT scan and gold standard intra-operative neurophysiological coordinates is a robust matric to pre-assess positive therapy outcomes- “good therapy” prediction if deviation is higher than 2.5 mm. When being less than 2.5 mm, adding directly calculated variables deviation (on Y and Z axis) would lead to specific assessment of “very good therapy”.







Similar content being viewed by others
References
Alzheimer’s Disease International (ADI). (2018). World Alzheimer Report 2018: The state of the art of dementia research: New frontiers. Alzheimer’s Disease International (ADI).
Bermudez, C., Rodriguez, W., Huo, Y., Hainline, A. E., Li, R., Shults, R., & Landman, B. A. (2019). Towards Machine Learning Prediction of Deep Brain Stimulation (DBS) Intra-operative Efficacy Maps. Proceedings of SPIE - The International Society for Optical Engineering.
Deuschl, G., Schade-Brittinger, C., et al. (2006). A Randomized Trial of Deep-Brain Stimulation for Parkinson’s Disease. New England Journal of Medicine, 355, 896–908.
Fisman, G. K., Herzog, J., Fisman, D., Lang, A. E., & Deuschl, G. (2006). Subthalamic Nucleus Deep Brain Stimulation: Summary and Meta-Analysis of Outcomes. Movement Disorders, 21(Suppl 14), S290–S304.
Follett, K. A., Weaver, F. M., Stern, M., et al. (2010). Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson’s Disease. New England Journal of Medicine, 362, 2077–2091.
Fraix, V., Houeto, J. L., Lagrange, C., et al. (2006). Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 77, 443–449.
Gervais-Bernard, H., Xie-Brustolin, J., Mertens, P., et al. (2009). Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: Five-year follow-up. Journal of Neurology, 256, 225–233.
Goetz, L., Bhattacharjee, M., Ferraye, M. U., Fraix, V., Maineri, C., Nosko, D., Fenoy, A. J., Piallat, B., Torres, N., Krainik, A., Seigneuret, E., David, O., Parent, M., Parent, A., Pollak, P., Benabid, A. L., Debu, B., & Chabardès, S. (2019). Deep Brain Stimulation of the Pedunculopontine Nucleus Area in Parkinson Disease: MRI-Based Anatomoclinical Correlations and Optimal Target. Neurosurgery, 84(2), 506–518. https://doi.org/10.1093/neuros/nyy151
Hastie, T., Tibshirani, R., & Friedman, J. (2017). The Elements of Statistical Learning. Springer.
Janikow, C. Z. (1998). Fuzzy decision trees: Issues and methods Man and Cybernetics. IEEE Press.
Krüger, R., Schuepbach, M., Deuschl, G., & EARLYSTIM study group. (2019). Quality of life predicts outcome of deep brain stimulation in early Parkinson disease. Neurology, 92(10), e1109–e1120. https://doi.org/10.1212/WNL.0000000000007037
Leoutsakos, J. M. S., Yan, H., Anderson, W. S., Asaad, W. F., Baltuch, G., Burke, A., & Lyketsos, C. G. (2018). Deep brain stimulation targeting the fornix for mild alzheimer dementia (the ADvance Trial): A two year follow-up including results of delayed activation. Journal of Alzheimer's Disease, 64(2), 597–606. https://doi.org/10.3233/JAD-180121
Liu, M., Zhang, D., & Shen, D. (2014). Alzheimer’s Disease Neuroimaging Initiative. Identifying informative imaging biomarkers via tree structured sparse learning for AD diagnosis. Neuroinformatics, 12(3), 381–94. https://doi.org/10.1007/s12021-013-9218-x
Livingston, G., Huntley, J., Sommerlad, A., et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet, 396(10248), 413–446. https://doi.org/10.1016/S0140-6736(20)30367-6
Moro, E., Lozano, A., Pollak, P., et al. (2010). Long-Term Results of a Multicenter Study on Subthalamic and Pallidal Stimulation in Parkinson’s Disease. Movement Disorders, 25, 578–586.
Rocca, W. A. (2018). The burden of Parkinson’s disease: a worldwide perspective. Elsevier open access.
Rodriguez-Oroz, M. C., Obeso, J. A., Lang, A. E., Houeto, J. L., Pollak, P., Rehncrona, S., & Van Blercom, N. (2005). Bilateral deep brain stimulation in Parkinson’s disease: A multicentre study with 4 years follow-up. Brain, 128, 2240–2249.
Sun, Z., Qiao, Y., Lelieveldt, B. P. F., & Staring, M. (2018). Alzheimer’s Disease NeuroImaging Initiative. Integrating spatial-anatomical regularization and structure sparsity into SVM: Improving interpretation of Alzheimer’s disease classification. NeuroImage, 178, 445–460. https://doi.org/10.1016/j.neuroimage.2018.05.051
Timmermann, L., Seijo, F., et al. (2015). Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson’s disease (the VANTAGE study): A non-randomised, prospective, multicentre, open-label study. Lancet Neurology, 14(7), 693–701.
Vergara, J. (2014). A review of feature selection methods based on mutual information. Neural Computing and Applications, 24, 175–186. https://doi.org/10.1007/s00521-013-1368-0
Vitek, J. L., Jain, R., Chen, L., Tröster, A. I., Schrock, L. E., House, P. A., & Starr, P. A. (2020). Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson’s disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study. The Lancet, 19.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors have no relevant financial or non-financial interests to disclose. The authors have no conflicts of interest to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Estella, F., Suarez, E., Lozano, B. et al. Design and Application of Automated Algorithms for Diagnosis and Treatment Optimization in Neurodegenerative Diseases. Neuroinform 20, 765–775 (2022). https://doi.org/10.1007/s12021-022-09578-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12021-022-09578-3